1. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis

   • Wenzhang Luo
   • Xiang Liu
   • Changren Huang

   Review 15 October 2021 Pages: 1731 - 1740

   

2. The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparison

   • Hatice Ozkan
   • Gareth Ambler
   • the SIGNaL collaborators

   Original Communication Open access 15 October 2021 Pages: 1741 - 1750

   

3. Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study

   • Samir Abu-Rumeileh
   • Benjamin Mayer
   • Makbule Senel

   Original Communication Open access 01 November 2021 Pages: 1751 - 1757

4. The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience

   • Anthony Feinstein
   • Maria Pia Amato
   • the CogEx Research Team

   Original Communication 05 November 2021 Pages: 1758 - 1763

5. Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre

   • Alvaro Cobo-Calvo
   • Ana Zabalza
   • Jaume Sastre-Garriga

   Original Communication 10 January 2022 Pages: 1764 - 1772

   

6. Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre

   • Alvaro Cobo-Calvo
   • Ana Zabalza
   • Jaume Sastre-Garriga

   Correction 22 February 2022 Pages: 1773 - 1773

7. COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitis

   • Simon Faissner
   • Daniel Richter
   • Ralf Gold

   Letter to the Editors Open access 25 August 2021 Pages: 1774 - 1775

   

8. Is Surfer’s myelopathy an acute hyperextension-induced myelopathy? A systematic synthesis of case studies and proposed diagnostic criteria

   • Carlos Alva-Díaz
   • Ethel Rodriguez-López
   • Kevin Pacheco-Barrios

   Review 03 September 2021 Pages: 1776 - 1785

   

9. Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders

   • Hesham Abboud
   • Andrea Salazar-Camelo
   • On-behalf of the Guthy-Jackson Foundation NMO International Clinical Consortium

   Review Open access 05 September 2021 Pages: 1786 - 1801

10. Eduard Gamper (1887–1938): cases and accidents

    • Evzen Ruzicka
    • Hartmann Hinterhuber
    • Hans Förstl

    Review Open access 13 September 2021 Pages: 1802 - 1808

    

11. Thrombectomy with or without thrombolysis in patients with acute ischemic stroke: a systematic review and meta-analysis

    • Xin Wu
    • Yi Ge
    • Zhong Wang

    Review 14 September 2021 Pages: 1809 - 1816

    

12. Multiple sclerosis epidemiological trends in Italy highlight the environmental risk factors

    • M. Puthenparampil
    • P. Perini
    • P. Gallo

    Review Open access 27 September 2021 Pages: 1817 - 1824

    

13. Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis

    • Lele Huang
    • Yujie Wang
    • Ruijun Zhang

    Review 09 October 2021 Pages: 1825 - 1833

    

14. The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson’s disease: a systematic review and meta-analysis

    • Yu-tong Zhao
    • Li Liu
    • Zong-yi Xie

    Review 15 October 2021 Pages: 1834 - 1850

    

15. Central positional nystagmus: an update

    • João Lemos
    • Michael Strupp

    Review 20 October 2021 Pages: 1851 - 1860

    

16. Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review

    • Francesca Washington
    • Dawn Langdon

    Review Open access 21 October 2021 Pages: 1861 - 1872

    

17. Virtual reality balance training to improve balance and mobility in Parkinson’s disease: a systematic review and meta-analysis

    • Elisabetta Sarasso
    • Andrea Gardoni
    • Davide Corbetta

    Review 28 October 2021 Pages: 1873 - 1888

    

18. Identifying falls remotely in people with multiple sclerosis

    • Valerie J. Block
    • Erica A. Pitsch
    • Jeffrey M. Gelfand

    Original Communication Open access 17 August 2021 Pages: 1889 - 1898

    

19. A preliminary comparison between ECAS and ALS-CBS in classifying cognitive–behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients

    • Lucia Catherine Greco
    • Andrea Lizio
    • Christian Lunetta

    Original Communication 19 August 2021 Pages: 1899 - 1904

    

20. Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis

    • Alessandro Salvalaggio
    • Daniele Coraci
    • Chiara Briani

    Original Communication Open access 19 August 2021 Pages: 1905 - 1912

    

21. Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry

    • Rosanna Rossi
    • Sara Molina
    • Karen M. Doyle

    Original Communication Open access 20 August 2021 Pages: 1913 - 1920

    

22. Neurological consequences of recreational nitrous oxide abuse during SARS-CoV-2 pandemic

    • Raphael Vollhardt
    • Julie Mazoyer
    • Bertrand Degos

    Original Communication 21 August 2021 Pages: 1921 - 1926

    

23. Clinical, oculographic and vestibular test characteristics of Ménière’s disease

    • Allison S. Young
    • Benjamin Nham
    • Miriam S. Welgampola

    Original Communication 22 August 2021 Pages: 1927 - 1944

    

24. Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)

    • Andreas Yiangou
    • James L. Mitchell
    • Alexandra J. Sinclair

    Original Communication Open access 22 August 2021 Pages: 1945 - 1956

    

25. PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice

    • Vicente Villanueva
    • Wendyl D’Souza
    • the PERMIT pooled analysis participants

    Original Communication Open access 24 August 2021 Pages: 1957 - 1977

    

26. Semi-automated assessment of the principal diffusion direction in the corpus callosum: differentiation of idiopathic normal pressure hydrocephalus from neurodegenerative diseases

    • Maria Eugenia Caligiuri
    • Andrea Quattrone
    • Aldo Quattrone

    Original Communication 24 August 2021 Pages: 1978 - 1988

    

27. Amyotrophic lateral sclerosis (ALS) among immigrant groups and Swedish-born individuals: a cohort study of all adults 18 years of age and older in Sweden

    • Per Wändell
    • Sten Fredrikson
    • Kristina Sundquist

    Original Communication Open access 24 August 2021 Pages: 1989 - 1995

28. Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders

    • Hiroki Masuda
    • Masahiro Mori
    • Satoshi Kuwabara

    Original Communication 29 August 2021 Pages: 1996 - 2003

    

29. Genes associated with grey matter volume reduction in multiple sclerosis

    • Jie Sun
    • Yingying Xie
    • Chunshui Yu

    Original Communication 29 August 2021 Pages: 2004 - 2015

    

30. Thyroid dysfunction in cerebral venous thrombosis: a retrospective cohort study

    • Simon Fandler-Höfler
    • Stefan Pilz
    • Thomas Gattringer

    Original Communication Open access 01 September 2021 Pages: 2016 - 2021

    

31. Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus

    • Anri Sakurai
    • Taiji Tsunemi
    • Nobutaka Hattori

    Original Communication 01 September 2021 Pages: 2022 - 2029

    

32. Detection of large vessel occlusion stroke with electroencephalography in the emergency room: first results of the ELECTRA-STROKE study

    • Laura C. C. van Meenen
    • Maritta N. van Stigt
    • Jonathan M. Coutinho

    Original Communication Open access 02 September 2021 Pages: 2030 - 2038

    

33. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study

    • Ivo Bozovic
    • Jelena Ilic Zivojinovic
    • Ivana Basta

    Original Communication 04 September 2021 Pages: 2039 - 2045

34. Prognostic factors for relapse and poor outcome in neuro-Behçet’s syndrome: results from a clinical long-term follow-up of a single centre

    • Didem Sahin Eroglu
    • Murat Torgutalp
    • Askin Ates

    Original Communication 04 September 2021 Pages: 2046 - 2054

    

35. Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning

    • Mauro Monforte
    • Sara Bortolani
    • Giorgio Tasca

    Original Communication 06 September 2021 Pages: 2055 - 2063

    

36. Adalimumab for CNS sarcoidosis: single-center experience and literature review

    • Spencer K. Hutto
    • Kevin Kyle
    • Nagagopal Venna

    Original Communication 06 September 2021 Pages: 2064 - 2072

    

37. Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM

    • Juan I. Rojas
    • Agustín Pappolla
    • Edgar Carnero Contentti

    Original Communication 07 September 2021 Pages: 2073 - 2079

    

38. Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019

    • Alberto Raggi
    • Lorenzo Monasta
    • Matilde Leonardi

    Original Communication 08 September 2021 Pages: 2080 - 2098

    

39. Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile

    • Joao Matos-Ribeiro
    • Paulo Castro-Chaves
    • Mariana Pintalhao

    Original Communication 09 September 2021 Pages: 2099 - 2112

40. Disrupted structural connectome and neurocognitive functions in Duchenne muscular dystrophy: classifying and subtyping based on Dp140 dystrophin isoform

    • Veeramani Preethish-Kumar
    • Apurva Shah
    • Madhura Ingalhalikar

    Original Communication 10 September 2021 Pages: 2113 - 2125

    

41. Cerebral amyloid angiopathy-related acute lobar intra-cerebral hemorrhage: diagnostic value of plain CT

    • Jean-Claude Baron
    • Grégoire Boulouis
    • Pascale Varlet

    Original Communication Open access 12 September 2021 Pages: 2126 - 2132

42. Glymphatic system dysfunction in patients with juvenile myoclonic epilepsy

    • Ho-Joon Lee
    • Dong Ah Lee
    • Kang Min Park

    Original Communication 12 September 2021 Pages: 2133 - 2139

    

43. The spectrum and differential diagnosis of acquired ocular motor nerve palsies: a clinical study of 502 patients

    • Rebecca Hörner
    • Jan Kassubek
    • Albert C. Ludolph

    Original Communication Open access 19 September 2021 Pages: 2140 - 2148

    

44. Psychological assessment of individuals with Mal de Débarquement Syndrome

    • Jeff Riley
    • Diamond Gleghorn
    • Yoon-Hee Cha

    Original Communication 19 September 2021 Pages: 2149 - 2161

    

45. The phenotypic spectrum of KCNT1: a new family with variable epilepsy syndromes including mild focal epilepsy

    • Christina Cherian
    • Juan P. Appendino
    • Karl Martin Klein

    Original Communication 19 September 2021 Pages: 2162 - 2171

    

46. Predictive semiology of psychogenic non-epileptic seizures in an epilepsy monitoring unit

    • Andrew J. Duncan
    • Ivana Peric
    • Udaya Seneviratne

    Original Communication 22 September 2021 Pages: 2172 - 2178

47. Does visuospatial motion perception correlate with coexisting movement disorders in Parkinson’s disease?

    • Sinem Balta Beylergil
    • Palak Gupta
    • Aasef G. Shaikh

    Original Communication 23 September 2021 Pages: 2179 - 2192

    

48. Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study

    • Elena Merli
    • Gian Maria Asioli
    • Giulia Pierangeli

    Short Commentary Open access 25 November 2021 Pages: 2193 - 2199

49. Recurrent intracerebral hemorrhage in patients with cerebral amyloid angiopathy: a propensity-matched case–control study

    • Aayushi Garg
    • Santiago Ortega‑Gutierrez
    • Nandakumar Nagaraja

    Short Commentary 17 January 2022 Pages: 2200 - 2205

    

50. Phoenix from the ashes: dramatic improvement in severe late-onset methylenetetrahydrofolate reductase (MTHFR) deficiency with a complete loss of vision

    • Anne-Sophie Biesalski
    • Sabine Hoffjan
    • Ilya Ayzenberg

    Letter to the Editors Open access 17 October 2021 Pages: 2206 - 2209